Cargando…
Differences between auto-fluorescence and tetracycline-fluorescence in medication-related osteonecrosis of the jaw—a preclinical proof of concept study in the mini-pig
OBJECTIVES: Fluorescence-guided bone surgery is a well-established technique in the treatment of medication-related osteonecrosis of the jaw. No histopathological evidence for bone auto-fluorescence is currently available, and thus, any differences from tetracycline-fluorescence remain unclear. Ther...
Autores principales: | Ristow, Oliver, Nehrbass, Dirk, Zeiter, Stephan, Arens, Daniel, Moratin, Julius, Pautke, Christoph, Hoffmann, Jürgen, Freudlsperger, Christian, Otto, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666678/ https://www.ncbi.nlm.nih.gov/pubmed/32444918 http://dx.doi.org/10.1007/s00784-020-03332-2 |
Ejemplares similares
-
A Drug Holiday Reduces the Frequency and Severity of Medication‐Related Osteonecrosis of the Jaw in a Minipig Model
por: Otto, Sven, et al.
Publicado: (2020) -
A critical assessment of the medication-related osteonecrosis of the jaw classification in stage I patients: a retrospective analysis
por: Ristow, Oliver, et al.
Publicado: (2021) -
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Otto, Sven, et al.
Publicado: (2021) -
Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model)
por: Troeltzsch, Matthias, et al.
Publicado: (2023) -
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
por: Wick, Alexander, et al.
Publicado: (2021)